Medicines & vaccines · Switzerland

Roche

Major genomics patent holder supplying KAPA library-prep and target-enrichment chemistry and developing its Sequencing by Expansion (SBX) NGS platform.

Headquarters
Basel, Switzerland · Europe
Value chain
Medicines & vaccines(Products); also Chemicals & gases
What that means
Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
Founded
1896
Staff
103,600 (2024)
Ownership
Listed
Listing
SIX:ROG on Google Finance
Website
roche.com
Relevance
High at its strongest, in Genomics & Biological Data

In 2 capabilities

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Equipment & materials · listed #6 of 50

    Major genomics patent holder supplying KAPA library-prep and target-enrichment chemistry and developing its Sequencing by Expansion (SBX) NGS platform.

    Relevance: Major library-prep, enrichment and sequencing IP holder

    Source · roche.com

  2. Biotechnology & Health Technologies · Design · listed #8 of 50

    Biologics leader (including Genentech) that produces Tamiflu and Xofluza influenza antivirals and is developing first-in-class antibiotics such as zosurabalpin.

    Relevance: Biologics leader and antiviral producer

    Source · en.wikipedia.org